Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. The Mount Sinai Physician’s Channel will show you some of the innovative procedures, new developments in patient care, and complex cases that are being performed in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field, and others.
Or call 212-241-4983
Recently Added
At Mount Sinai, we are relentless in our mission to overcome some of the most perplexing health and scientific problems of our time—always with an eye to the patients and communities we serve. In this issue, we offer a glimpse into how ...
Mount Sinai Experts Explain What the Omicron Variant Means for You
Currently, there is insufficient data on how easily the Omicron variant may be transmitted or whether it produces more serious illness.
Monkeypox
Curious About the Monkeypox Vaccine? Here’s What You Need to Know
Richard Silvera, MD, MPH of Mount Sinai details important information about monkeypox vaccination.
Cardiology & Cardiovascular Surgery | View More
Valentín Fuster, MD, PhD, Named President of Mount Sinai Heart
Mount Sinai Health System’s globally acclaimed cardiologist Valentín Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023.
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart
Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has been named Director of Mount Sinai Heart.
Annapoorna S. Kini, MD, Reports on Latest YELLOW III Study Results
Twenty-six weeks of PCSK9 inhibitor therapy on top of maximally tolerated statins increases markers of plaque stability in patients with stable coronary artery disease, according to the YELLOW III trial, led by Annapoorna S. Kini, MD, ...
A unique Mount Sinai study focused on a multiethnic, underserved community in Harlem found that young non-Hispanic Black adult participants were twice as likely to have atherosclerosis as young Hispanic adults.
Dermatology | View More
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped.
Brian S. Kim, MD, MTR, presented virtually as a keynote speaker, at the Anesthesiology Branch of Chinese Geriatric Society 2022 Annual Meeting, Tianjin, China. This popular presentation’s total online viewing clicks were more than 400,000 during the meeting.
Brian S. Kim, MD, MTR, received the inaugural Stephen I Katz, MD, PhD, International Lectureship Award and presented "Neuroimmune Regulation of Itch" at the Society for Investigative Dermatology (SID) annual meeting in Portland, Oregon in May 2022.
"Spotlighting Alopecia” with Emma Guttman-Yassky, MD, PhD
"Spotlighting Alopecia” with Emma Guttman-Yassky, MD, PhD, featured an in depth discussion with Louis DePalo, MD, from the Health Center at Hudson Yards.
Diabetes & Endocrinology | View More
New Study Identifies Better Treatment Option for Common Complication of Dialysis
A Mount Sinai study has identified a better treatment option to treat arteriovenous fistulas, a common complication of hemodialysis
Retinal Imaging and Management of Diabetic Retinopathy
Gareth Lema, MD, PhD, discusses diagnostic imaging technology and treatment for diabetic retinopathy in this Grand Rounds presentation
Euglycemic Diabetic Ketoacidosis in the Modern Era
David W. Lam, MD, discusses euglycemic diabetic ketoacidosis in this Grand Rounds presentation
Gastroenterology & GI Surgery | View More
Targeting Disease Prediction and Prevention: The New Frontier in IBD
Mount Sinai researchers have found strong evidence that before the first symptoms of Crohn’s disease and ulcerative colitis occur, there’s a preclinical phase in which immune and inflammatory pathways are already altered.
Vedolizumab Versus Adalimumab for Moderate to Severe Ulcerative Colitis
In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Ustekinumab is more effective than placebo as an induction and maintenance therapy for UC.
Geriatrics | View More
Geriatrics and Palliative Medicine 2023 Specialty Report
The Mount Sinai Hospital is ranked No. 1 in Geriatrics in the nation by U.S. News & World Report for the third consecutive year.
Leslie Kerr, MD, in a Grand Rounds presentation on joint inflammation
Treatment for crystals in synovial fluid in patients with multiple medical issues
Albert L. Siu, MD, presents Grand Rounds on geriatrics and palliative care
Hospitalization at Home
Forty Years of Excellence: Research Focused on Patient Needs
Robert Butler, MD, having previously founded and chaired the National Institute on Aging, quickly established a highly successful culture of research, and that culture continues to flourish.
Interventional Radiology | View More
Mount Sinai Neurosurgery Chair, Joshua Bederson, MD Case Study: Brain Tumor Embolization
The Benefits of Preoperative Embolization for Treating Meningiomas and Other Skull Base Tumors
An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.
Prostatic Artery Embolization at Mount Sinai
Watch a PAE on a 74-year-old with a 20-year history of BPH
An Overview of Minimally Invasive Prostate Artery Embolization at Mount Sinai
Hear directly from Aaron Fischman, MD, about how effectively PAE works for patients with urinary symptoms caused by BPH
Neurology & Neurosurgery | View More
Mount Sinai Neurosurgery Chair, Joshua Bederson, MD Case Study: Brain Tumor Embolization
The Benefits of Preoperative Embolization for Treating Meningiomas and Other Skull Base Tumors
Simultaneous Minimally Invasive Surgery (MIS) for Spontaneous Intracerebral Hemorrhage (sICH) Evacuation and Pulmonary Embolectomy (PE)
Deep Brain Stimulation (DBS) for Obsessive-Compulsive Disorder (OCD)
View the Pre- and Post- Operative Presentation of Deep Brain Stimulation (DBS) Procedure to Treat Obsessive-Compulsive Disorder (OCD)
Mount Sinai Neurosurgeon presents Efficient, Radiation-Free Navigation: Ushering in a New Era of Spine Surgery
Nuclear Medicine | View More
This large study of patients undergoing PET MPI demonstrated that although reduced MBFR was more prevalent in women compared with men, there were no sex-specific differences in the prognostic value of reduced MBFR.
This study reviews the need for a separate risk threshold with PET and SPECT while selecting a high-risk population as the target for an intervention.
Use of anatomic testing such as coronary artery calcium scoring (CACS) of 0 to avoid myocardial perfusion imaging in symptomatic patients could lead to missing microvascular dysfunction in 4 out of 10 patients, a finding associated with a high mortality risk.
Myocardial perfusion imaging (MPI) identifies abnormalities that occur early in the ischemic cascade leading to angina.
Obstetrics & Gynecology | View More
Oncology | View More
Two Renowned Cancer Experts to Head New Tisch Cancer Hospital at The Mount Sinai Hospital
Cardinale B. Smith, MD, PhD, has been appointed Chief Medical Officer for the Tisch Cancer Hospital and Vice President of Cancer Clinical Affairs, and Ash Tewari, MBBS, MCh, has been appointed Surgeon-in-Chief of the Tisch Cancer Hospital.
Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder Patients
Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo, according to clinical trial results shared in a late-breaking oral presentation at the American Society ...
Nina Bhardwaj, MD, PhD, was honored with the 2022 ESMO Award for Immuno-Oncology from the European Society for Medical Oncology in recognition of her outstanding contributions to cancer immunology research.
Clinical Trials for Challenging Cancer Cases at The Tisch Cancer Institute at Mount Sinai
The Tisch Cancer Institute (TCI) offers a robust portfolio of clinical trials that span multiple cancers.
Ophthalmology | View More
New York Eye and Ear Infirmary of Mount Sinai (NYEE) 2022 Specialty Report
We are pleased to share with you the Department of Ophthalmology 2022 Specialty Report, which showcases the tremendous work happening at our institution, as we continue to envision our third century of community care, vision research, and education.
A Mount Sinai Resident Draws on a Diverse Team to Address a Traumatic Eye Injury
The case of a 56-year-old man with a 10mm shard of metal penetrating his left eye shows the importance of triage in ensuring the best outcomes.
Surgeons at NYEE and Mount Sinai Team Up for a Five-Year-Old Patient
Technology and surgical skills come together as surgeons team up to repair an arteriovenous malformation in the orbit compressing the optic nerve.
Two Powerful Imaging Tools Make Their Debut in the United States
Technology continues to hold center stage at New York Eye and Ear Infirmary of Mount Sinai (NYEE), underscored by the recent arrival of two cutting-edge imaging devices: a tear film analyzer and an optical coherence tomography (OCT) Doppler.
Orthopedics | View More
Orthopedic Surgery Specialty Report 2023
Since 1910, Mount Sinai’s Department of Orthopedic Surgery has been dedicated to understanding health conditions spanning the field of orthopedics.
New Head of Mount Sinai Hand Fellowship Is Doubling Down on Educational Opportunities
The Hand and Upper Extremity Fellowship Program at Mount Sinai, among the oldest and most competitive fellowships of its kind, welcomes Jaehon Kim, MD, as its new director.
3D Printing Provides a Sturdy Pillar for Total Ankle Replacement Surgery
Conventional structural bone grafts for ankle and foot reconstruction are difficult to contour to a patient’s anatomy and often degrade over time.
During the 2021-2022 academic year, the Department of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai added three talented physicians to its roster: Joseph Lee, MD, Nilsson Holguin, MD, and Fei Fang, PhD.
Otolaryngology/ENT | View More
On Wednesday, January 13, 2021, a team of brilliant medical professionals conducted the first successful human trachea transplant. This special report details the research and process leading up to this historic surgery, as well as the ...
How Surgeons Performed the First Successful Human Trachea Transplant
More than 50 specialists were involved in the first successful human trachea transplant. The skilled team spent 18 hours harvesting trachea from a donor and implanting it into the patient
Otolaryngology - Head and Neck Surgery 2023 Specialty Report
Eric M. Genden, MD, MHA, FACS, Professor and Chair, Otolaryngology-Head and Neck Surgery, reflects on a bold year for the Department that resulted in groundbreaking research and the adoption of cutting-edge technology.
Genetic Causes of Three Previously Unexplained Rare Diseases Identified
Mount Sinai researchers help identify previously unknown genetic causes of primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness.
Mount Sinai Kravis Children's Hospital| View More
Lisa Satlin, MD shares insights on Pediatrics
Lisa Satlin, MD, Shares Insights on Pediatrics at Mount Sinai Kravis Children’s Hospital
Jeffrey M. Saland, MD discusses determining "normal" blood pressure in children
Jeffrey M. Saland, MD, on Determing “normal” Blood Pressure in Children
Alfin Vicencio, MD discusses his success with precision medicine
Alfin Vicencio, MD, Targets Asthma in Children With Precision Medicine
People with Down syndrome have less frequent but more severe viral infections.
Psychiatry| View More
Psychiatry Specialty Report 2023
The year 2022 was a productive and prolific one for our department. We launched the Center for Disease Neurogenomics—one of the few in the world with access to brain tissue and population-level datasets.
This study is the first to examine in utero exposure to stimulants and long term child outcomes. Researchers examined almost 900 children who were exposed to ADHD during the mothers’ pregnancy and 1270 children who were not.
Mount Sinai Researchers Have Identified Two Previously Unknown Genes Linked to Schizophrenia
Researchers have identified two previously unknown genes linked to schizophrenia and newly implicated a third gene as carrying risk for both schizophrenia and autism.
Deep Brain Stimulation (DBS) for Obsessive-Compulsive Disorder (OCD)
View the Pre- and Post- Operative Presentation of Deep Brain Stimulation (DBS) Procedure to Treat Obsessive-Compulsive Disorder (OCD)
Pulmonology | View More
Pulmonary, Critical Care and Sleep Medicine 2023 Specialty Report
We challenged expectations to achieve progress in 2022 in areas ranging from asthma to pleuroscopy, exercise physiology, and lung transplant.
Asthma and COPD Expert Is Mount Sinai's New Chair of Medicine
Mount Sinai has named Monica Kraft, MD, as its new Chair of Medicine. She will now lead a department she has long collaborated with on research.
Ensuring ICUs Have the Tools to Manage the Next Crisis
Mount Sinai's medical intensive care unit is adjusting to the "new normal" post-pandemic by ensuring that its teams have the tools to manage future crises.
Unexplained Shortness of Breath? Exercise Physiology Yields Answers in 10 Minutes
Mount Sinai's exercise physiology program, which went dormant during the COVID-19 pandemic, has been revitalized with a new leader, sleek state-of-the-art hardware, software upgrades, and more.
Rehabilitation | View More
Quad Gods Defy the Odds, Take Gaming to New Heights
A patient struggling to adjust to his quadriplegia gains the idea to form a competitive e-sports team with other similar patients from Mount Sinai, and the team has gone on to win tournaments, even against other players without disabilities.
Taking Emotional Dysregulation Intervention Online Shows Promise
Building on decades of progress of emotional dysregulation intervention research, Mount Sinai scientists launched a randomized controlled trial using online video conferencing to deliver a therapy that targets emotional dysregulation post-traumatic ...
At Mount Sinai’s Lazarus Center, Kids Take Center Stage
The mission of the Charles Lazarus Children’s Abilities Center at the Icahn School of Medicine at Mount Sinai is ambitious: To provide children who have disabilities with every tool, resource, and opportunity possible to achieve their full potential.
Minimally Invasive Technology Offers Paralyzed People Greater Function
For the first time in the United States, people with severe paralysis are receiving minimally invasive implants that allow them to communicate and perform computer-based tasks at home.
Urology | View More
Message from the Chair: Milestones are meant to be celebrated and surpassed. For the year 2022, our milestones are a reflection of our collective efforts to save lives—through innovative patient care and groundbreaking research and scholastic activities.
An innovative effort by the Milton and Carroll Petrie Department of Urology and Ash Tewari, MBBS, MCh, FRCS (Hon.), Professor and System Chair, to improve early detection of prostate cancer among at-risk populations in New York City...
Organoids Enable Pathophysiology, Treatment Studies of Rare Renal Cell Carcinomas
For years, rare renal cell carcinomas (RCCs), such as papillary RCC, have been understudied because their incidences are too low to support clinical trials.
Better Diagnosis Holds the Key to Improved Outcomes for BPH Patients
As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. The Mount Sinai Physician’s Channel will show you some of the innovative procedures, new developments in patient care, and complex cases that are being performed in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field, and others.